ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection

BACKGROUND: While Zika virus (ZIKV) infection is typically self-limited, congenital birth defects and Guillain-Barré syndrome are well-described. There are no therapies or vaccines against ZIKV infection. METHODS: ZIKA-001 is a phase I, open label, clinical trial designed to evaluate the safety, sid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Tebas, Pablo, Roberts, Christine C, Muthumani, Kar, Reuschel, Emma, White, Scott, Khan, Amir S, Racine, Trina, Choi, Hyeree, Zaidi, Faraz, Boyer, Jean, Kudchodkar, Sagar, Park, Young K, Trottier, Sylvie, Remigio, Celine, Krieger, Diane, Kobinger, Gary P, Weiner, David, Maslow, Joel
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631827/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.693
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados